NCT05028348
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05028348
Title A Study of Combination of Selinexor, Pomalidomide, and Dexamethasone (SPd) Versus Elotuzumab, Pomalidomide, and Dexamethasone (EloPd) in Subject With Previously Treated Multiple Myeloma
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors European Myeloma Network B.V.
Indications
Therapies
Age Groups: adult | senior
Covered Countries GRC | FRA | ESP | DEU

Facility Status City State Zip Country Details
CHRU Hôtel Dieu Nantes France Details
CHU Hôpital Saint Antoine Paris France Details
La Pitié Paris France Details
Klinikum Chemnitz Chemnitz Germany Details
Marien Hospital Dusseldorf Düsseldorf Germany Details
University Medicine Greifswald, Medical Clinic and Polyclinic for Internal Medicine Greifswald Germany Details
Universitätsklinikum Hamburg - Eppendorf Hamburg Germany Details
Alexandra General Hospital -Department of Clinical Therapeutics N.K. Univ. of Athens Athens Greece Details
Hospital Clinic I Provincial de Barcelona Barcelona Spain Details
Hospital Universitari Vall d'Hebron Barcelona Spain Details
Institut Catala D Oncolocia Hospitalet - Hospital Duran i Reynals Barcelona Spain Details
Hospital de Cabueñes Gijón Spain Details
Institut Català D'Oncologia - Hospital Dr. Josep Trueta Girona Spain Details
Hospital Universitario 12 de Octubre Madrid Spain Details
H. General Universitario Morales Meseguer Murcia Spain Details
Clínica Universidad de Navarra (CUN) Pamplona Spain Details
Hospital Universitario de Salamanca Salamanca Spain Details
H. Universitario Marqués de Valdecilla Santander Spain Details
Complejo Hospitalario Universitario de Santiago (CHUS) Santiago de Compostela Spain Details
H.U. La Fe Valencia Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field